Alopecia

Latest News

Androgenetic alopecia | Image Credit: andranik123 - stock.adobe.com
Low-Dose Oral Minoxidil Effective for Various Hair Loss Disorders

November 20th 2024

Low-dose oral minoxidil has been agreed upon by an international expert panel as an effective treatment for various hair loss conditions, such as alopecia, with guidelines provided for safe and effective use.

Man with alopecia undergoing an examination | image credit: alsu0112 - stock.adobe.com
Review: Approving, Using JAK Inhibitors for Better Alopecia Areata Outcomes

November 14th 2024

Kristen Whitney, DO, FAAD, dermatologist at Allegheny Health Network.
Managing Alopecia Areata and Coexisting Conditions

November 12th 2024

Kristen Whitney, DO, FAAD, dermatologist at Allegheny Health Network.
Alopecia Areata Treatment Advancements and Emerging Technology

November 4th 2024

Clinical trial researchers interact with data. | Image Credit: elenabsl - stock.adobe.com
Alopecia Areata Risk in Patients With IBD Tied to Anti-TNF Use

October 31st 2024

More News

Woman holding brush full of hair | Image Credit: anaumenko - stock.adobe.com
May 31st 2024

History of Oral Contraceptive Use, Gene Variant May Increase Risk of FFA

Cameron Santoro
A case controlled study suggests a gene variant may offer some protection from frontal fibrosing alopecia (FFA), but only if there is no prior history of oral contraceptive pill use, which appears to increase the risk for carriers of this variant.
Male pattern baldness | Image Credit: Oksana - stock.adobe.com
May 30th 2024

Patients With AGA Treated With PRP Display Hair Regrowth, Potential Microbiome Rebalance

Cameron Santoro
Platelet-rich plasma (PRP) treatment increased hair regrowth in patients with androgenetic alopecia (AGA) and may help rebalance the scalp microbiome, although the link between the microbiome changes and hair growth needs future investigations.
Receding hairline | Image Credit: Bongkochrut - stock.adobe.com
May 28th 2024

Primary Cicatricial Alopecia Connected to Increased Risk of Endocrine, Metabolic Diseases

Cameron Santoro
A study using a large Korean health database found that people with a rare hair loss disorder called primary cicatricial alopecia were more likely to also have additional health problems like diabetes and high blood pressure compared with people who had other hair loss conditions or no hair loss at all.
Microneedling hair loss treatment | Image Credit: Dharma - stock.adobe.com
May 14th 2024

Scalp Repair Serum Microneedling: Fewer Treatments, More Hair Regrowth for AGA

Cameron Santoro
A study found scalp repair serum microneedle combined therapy with medication to improve hair growth outcomes for patients with moderate to severe androgenetic alopecia (AGA) and reduce the number of microneedling sessions necessary.
Illustration of patient with AA at doctor | Image Credit: Rudzhan - stock.adobe.com
May 13th 2024

Alopecia Areata Risk Associated With Atopy, Allergies

Cameron Santoro
A genetic study suggests people with allergies and eczema are more likely to develop alopecia areata, an autoimmune disease that causes hair loss. Researchers believe this link may be due to similar immune system responses.
Mature woman with alopecia. | Image Credit: highwaystarz - stock.adobe.com
May 7th 2024

AA Unlikely to Cause Anxiety, Depression but May Be Affected by Mental Illness

Cameron Santoro
A Mendelian randomization study using genetic analysis found that alopecia areata (AA) increases the risk of anxiety and depression, but not the other way around, providing unique evidence for a causal link while adding to existing evidence.
Thin hair loss on non-White man | Image Credit: Alessandro Grandini - stock.adobe.com
April 25th 2024

Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations

Cameron Santoro
A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Woman with hair loss | Image Credit: Creative Cat Studio - stock.adobe.com
April 17th 2024

Severe AA Impairs Quality of Life, Study Calls for Holistic Management Strategies

Cameron Santoro
A survey study found a strong association between severe alopecia areata (AA) and significant impairments in quality of life and mental wellbeing, highlighting the need for comprehensive treatment addressing both physical and emotional aspects of the disease.
Physician diagnoses hair loss, alopecia | Image Credit: buravleva_stock - stock.adobe.com
April 14th 2024

AA May Increase Risk of Hypothyroidism, AG Needs Further Investigation

Cameron Santoro
Potential links between alopecia areata (AA) and hypothyroidism were observed among the study but the connection between androgenetic alopecia (AG) and hypothyroidism needs further investigation.
Man with hair loss measuring regrowth | Image Credit: Pixel-Shot - stock.adobe.com
April 10th 2024

Laser-Assisted Drug Delivery Is Effective in Alopecia but Lacks Comparison With Existing Treatments

Cameron Santoro
Studies show that laser-assisted drug delivery (LADD) improves hair growth in patients with alopecia. However, researchers are still looking at the best ways to compare LADD's effectiveness against other methods like microneedling.
Male pattern baldness. | Image Credit: boyloso - stock.adobe.com
April 8th 2024

Treatment Targeting CXCL12 Protein Offers Hope for Patients With AGA, AA

Cameron Santoro
Antibodies targeting the CXCL12 protein show potential to promote hair growth in conditions like androgenic alopecia (AGA) and alopecia areata (AA), offering hope for new treatment options.
Doctor examines child scalp. | Image Credit: Nadzeya - stock.adobe.com
April 4th 2024

Combination Therapies Optimize Hair Regrowth in Pediatric Patients With AA

Cameron Santoro
Corticosteroids are the most common treatment for pediatric patients with alopecia areata (AA), but promising newer options like JAK inhibitors are emerging. This review highlights the importance of personalized treatment plans and maximizing response through combination therapies.
Dermatologist checks woman's scalp. | Image Credit: Andrey Popov - stock.adobe.com
March 29th 2024

Light Therapy Clothing Shows Potential for Mild Psoriasis, PMLE, AA Treatment

Cameron Santoro
Red and near-infrared–emitting fabric clothing may improve symptoms of mild psoriasis, polymorphous light eruption (PMLE), and alopecia areata (AA), but further research with larger groups is needed due to limitations in the pilot study design.
Woman worried about hair loss | Image Credit: Prostock-studio - stock.adobe.com
March 27th 2024

Alopecia Areata Impacts Patient Perception, Quality of Life

Cameron Santoro
Patients with alopecia areata (AA) often perceive their hair loss as more severe than dermatologists do, leading to increased emotional and social problems. This study highlights the importance of understanding patient perception for better treatment and improved quality of life.
Before and after hair regrowth, rear view of male head | Image Credit: Sebastian - stock.adobe.com
March 20th 2024

Tofacitinib Effective for AA, Earlier Intervention Improves Outcomes

Cameron Santoro
Research suggests tofacitinib effectively treats alopecia areata (AA), particularly when used early for severe cases. This offers promising evidence for doctors to consider when making treatment plans for patients.
Woman experiences hair loss | Image Credit: Siam - stock.adobe.com
March 14th 2024

Deuruxolitinib Demonstrates Efficacy, Tolerability in Patients With Moderate to Severe AA

Cameron Santoro
Posters suggest deuruxolitinib, a medication targeting specific cellular pathways, effectively promotes hair regrowth in patients with moderate to severe alopecia areata (AA) and results in minimal adverse events.
Alopecia surrounded by medication | Image Credit: greenapple78 - stock.adobe.com
March 13th 2024

Review Finds JAK Inhibitors More Effective for Moderate to Severe AA Compared With Established Therapies

Cameron Santoro
Baricitinib and other oral JAK inhibitors show promise as effective treatments for moderate-to-severe alopecia areata (AA), with fewer adverse effects compared with traditional options.
Dermatologist checks patient's scalp, wearing surgical masks | Image Credit: Andrey Popov - stock.adobe.com
March 9th 2024

Study Finds No Link Between COVID-19 Vaccine, Alopecia Areata

Cameron Santoro
A study in San Bernardino County found no increased risks of alopecia areata (AA) after the COVID-19 vaccination but suggests further research into potential geographic and gender-based factors.
Hair loss in brush and medicine on table | Image Credit: Viktoriia M - stock.adobe.com
March 5th 2024

Baricitinib Shows Effectiveness, Safety for Severe AA With Room for Further Exploration

Cameron Santoro
A study found baricitinib to be safe and effective for treating severe alopecia areata (AA) but expressed the need for more long-term trials to support these findings.
Woman with hair loss | Image Credit: New Africa - stock.adobe.com
February 29th 2024

Experts Measure AA Severity With Key Factors, Reach Consensus on Treatment Decisions

Cameron Santoro
An expert survey using the eDelphi method pinpointed disease duration, treatment response, and mental health as crucial factors in a new multidimensional tool known as Alopecia Areata Severity and Morbidity Index (ASAMI), underlining the importance of personalized treatments for future research incorporating patient perspectives.
Woman removing wig | Image Credit: Seventyfour - stock.adobe.com
February 23rd 2024

Gender Differences, Disease Severity, Income Disparities Drive Financial Burden in AA

Cameron Santoro
Women with alopecia areata (AA), especially those with severe symptoms and lower income, face significant financial burden managing the condition.
Physician prescribing AA treatment to patient | Image Credit: buritora - stock.adobe.com
February 17th 2024

Patient, Physician Viewpoints Differ Regarding AA Severity, Treatment Satisfaction

Cameron Santoro
A Japanese study of alopecia areata (AA) found misalignment between patient and doctor perceptions of severity, limiting treatment options, and leading to dissatisfaction and unmet needs.
Alopecia surrounded by medication | Image Credit: greenapple78 - stock.adobe.com
February 14th 2024

Targeting T-Cell–Based Therapies to Treat Alopecia Areata

Cameron Santoro
New research explores T cells and their signaling pathways in alopecia areata (AA), highlighting promising drug targets for future treatment.
Doctor reviewing medical research | Image Credit: Geber86 - stock.adobe.com
February 9th 2024

Study Finds AA Associated With Connective Tissue, Ocular Diseases and Vitamin D Deficiency

Cameron Santoro
Meta-analysis results identify high and low associations of various comorbidities like vitamin D deficiencies, ocular diseases, among others in patients with alopecia areata (AA), to promptly manage and improve treatment outcomes.
Doctor using magnifying glass to view scalp regrowth | Image Credit: Elnur - stock.adobe.com
February 7th 2024

Study Finds Significant Hair Regrowth in Patients With Patchy AA Following Baricitinib Treatment

Cameron Santoro
Baricitinib was found to be an effective treatment for patchy alopecia areata (AA), in a retrospective study, with most patients experiencing hair regrowth after 4 to 16 weeks of treatment.
Hair loss treatment medicines | Image Credit: KenamiRyoko- stock.adobe.com
January 29th 2024

AA Treatment: Comparing Topical Treatments, Microneedling, Tofacitinib

Cameron Santoro
Topical treatments and minoxidil solutions were found to be the most effective, safe, and affordable first-line options for treating pediatric AA.
Worried woman looking at scalp | Image Credit: Pormezz - stock.adobe.com
January 25th 2024

Tofacitinib as AA Treatment Has High Drug Survival Rates, Manageable Side Effects

Cameron Santoro
A study from China found that tofacitinib was an effective treatment for alopecia areata (AA), with most patients achieving complete or partial hair regrowth and experiencing tolerable side effects.
Doctor examining child's scalp | Image Credit: New Africa - stock.adobe.com
January 20th 2024

Topical Corticosteroids: The Preferred First-Line Treatment for Pediatric Alopecia Areata

Cameron Santoro
A survey of pediatric dermatologists revealed that topical corticosteroids are the most common first-line treatment for children with alopecia areata, regardless of age or hair loss severity.
Itchy scalp with braids | Image Credit: Andrey Popov - stock.adobe.com
January 18th 2024

Evaluating Hair Camouflage as a Tool for Black Women With Alopecia: A Critical Review

Cameron Santoro
Black women with alopecia often struggle between concealing their hair loss and protecting their fragile scalps, all while seeking to express their cultural identity and build self-confidence.
Woman worried about hair loss | Image Credit: Andrey Popov - stock.adobe.com
January 13th 2024

Disparities in Clinical Trial Enrollment, Retention Among Marginalized Racial and Ethnic Groups With AA

Cameron Santoro
A US study found alopecia areata (AA) is more common in non-White patients, likely due to underrepresentation in dermatology, leading to less consideration of AA as a diagnosis for non-White individuals.
<123>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo